Ho Carole
- SEC CIK
- 0001724605
No open-market purchases or sales filed in the past year.
Current role at each company
- RPRX Royalty Pharma plcDirectoras of Jun 8, 2026
- DNLI Denali Therapeutics Inc.Chief Medical Officeras of Aug 14, 2025
- BEAM Beam Therapeutics Inc.Directoras of Jun 6, 2025
- NGM NGM Biopharmaceuticals IncDirectoras of Apr 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ho Carole as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DNLI Denali Therapeutics Inc.
Chief Medical Officer25 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 (view filing) | Aug 12-13 | 2 days | Ho CaroleChief Medical Officer | SSale | −3.74K | $13.81 | −$51.7K | −1.7%216.6K after | 2 lots10b5-1 |
| Jan 8, 2025 (view filing) | Jan 6-7 | 2 days | Ho CaroleChief Medical Officer | SSale | −15.2K | $20.33 | −$308.3K | −7.9%175.7K after | 2 lots |
| Aug 22, 2024 (view filing) | Aug 20-21 | 2 days | Ho CaroleChief Medical Officer | SSale | −22.5K | $24.49 | −$549.9K | −15.9%118.8K after | 3 lots10b5-1 |
| Aug 15, 2024 (view filing) | Aug 13 | 2 days | Ho CaroleChief Medical Officer | SSale | −2.34K | $22.89 | −$53.5K | −1.6%141.3K after | |
| Feb 15, 2024 (view filing) | Feb 13-14 | 2 days | Ho CaroleChief Medical Officer | SSale | −4.19K | $17.46 | −$73.1K | −2.8%143.6K after | 2 lots10b5-1 |
| Jan 12, 2024 (view filing) | Jan 10 | 2 days | Ho CaroleChief Medical Officer | SSale | −4.67K | $19.02 | −$88.8K | −3.1%147.8K after | 10b5-1 |
| Jan 9, 2024 (view filing) | Jan 5 | 4 days | Ho CaroleChief Medical Officer | SSale | −9.97K | $19.43 | −$193.8K | −4.8%198.8K after | |
| Aug 25, 2023 (view filing) | Aug 23 | 2 days | Ho CaroleChief Medical Officer | SSale | −2.52K | $23.22 | −$58.6K | −1.4%182.8K after | |
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | Ho CaroleChief Medical Officer | SSale | −2.48K | $22.60 | −$56.0K | −1.3%185.3K after | |
| Aug 16, 2023 (view filing) | Aug 14 | 2 days | Ho CaroleChief Medical Officer | SSale | −2.77K | $23.79 | −$65.9K | −1.5%182.8K after | 10b5-1 |